(Q55471231)

12 July 2018

title

Survivin is a negative prognostic marker in medulloblastoma. (English)

1 reference

12 July 2018

0 references

Pizem J

1

1 reference

12 July 2018

Cört A

series ordinal

2

1 reference

12 July 2018

Zadravec-Zaletel L

series ordinal

3

1 reference

12 July 2018

Popovic M

series ordinal

4

1 reference

12 July 2018

publication date

1 August 2005

1 reference

12 July 2018

Neuropathology and Applied Neurobiology

published in

1 reference

12 July 2018

volume

31

1 reference

12 July 2018

issue

4

1 reference

12 July 2018

page(s)

422-428

1 reference

12 July 2018

Prognostic factors in medulloblastoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Medulloblastoma: signalling a change in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

The role of survivin as a new target of diagnosis and treatment in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Survivin and molecular pathogenesis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

The molecular basis and potential role of survivin in cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Differential subcellular localization of functionally divergent survivin splice variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Aberrant regulation of survivin by the RB/E2F family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Tumor suppressor genes and medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Role of Wnt pathway in medulloblastoma oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2005.00664.X

10.1111/J.1365-2990.2005.00664.X

21 January 2018

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018